Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies (CVE:HIV – Free Report) to a moderate buy rating in a research note issued to investors on Wednesday morning,Zacks.com reports.
A number of other equities research analysts also recently issued reports on the company. Roth Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th. Northland Capmk raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Thursday, September 19th. Finally, Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Four equities research analysts have rated the stock with a strong buy rating, According to data from MarketBeat.com, the stock has an average rating of “Strong Buy”.
Check Out Our Latest Report on HIVE Blockchain Technologies
HIVE Blockchain Technologies Stock Performance
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- Do ETFs Pay Dividends? What You Need to Know
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Insider Buying Explained: What Investors Need to Know
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
